US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

256.77

+6.372.54%

Volume:96.01K

Turnover:24.53M

Market Cap:506.99M

PE:- -

High:259.40

Open:255.78

Low:250.92

Close:250.40

52wk High:341.93

52wk Low:76.29

Shares:1.97M

Float Shares:1.97M

Volume Ratio:0.86

T/O Rate:4.86%

Dividend:1.00

Dividend Rate:0.39%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Solid Biosciences' Duchenne Muscular Dystrophy Approach, FDA Shift Support Upside, RBC Says

MT Newswires Live

Philips Wins Top ITEA Awards for AI‑Driven Healthcare and Sensing Innovation

Sector Update: Healthcare

MT Newswires Live

NeOnc’s $629K Insider Buying Spree Follows Breakthrough Data and Now All Eyes Turn to the FDA

Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), Ascendis Pharma (ASND) and Charles River Labs (CRL)

Analysts Offer Insights on Healthcare Companies: Viatris (VTRS) and Vera Therapeutics (VERA)

NRX Pharmaceuticals Gains FDA Boost for Ketamine Review

Analysts’ Top Healthcare Picks: Alnylam Pharma (ALNY), Scholar Rock Holding (SRRK)

Meinian Onehealth Healthcare Holdings Shareholder Reduces Stake

MT Newswires Live

Sigma Healthcare Director Neville Mitchell Boosts Shareholding

Positive Report for Alvotech (ALVO) from Barclays

Singapore Healthcare Firm LYC Healthcare Sets IPO Price at $4 Per Share, Upsizes Offering by 67% to $25 Million

Amplia Showcases FAK Oncology Pipeline at E&P Healthcare Conference

Aurobindo Pharma's API Unit Receives One US FDA Observation

MT Newswires Live

EBR Systems Plans FDA Label Update for WiSE System in Q4

MT Newswires Live

Emyria takes Australian psychedelic treatment model to U.S. FDA

Dimerix to Showcase Kidney Disease Pipeline and Growth Strategy at E&P Healthcare Conference

Beta Bionics Secures FDA Clearance for Mint Patch Pump

Health Care Down, but not by Much, on Rotation to Less Inflation-Sensitive Areas

Indivior accelerates transition from RB manufacturing agreement

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigerfiesta.com/stock/LABU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":256.77,"timestamp":1789575349258,"preClose":250.4,"halted":0,"volume":96008,"delay":0,"changeRate":0.025439297124600545,"floatShares":1974486,"shares":1974486,"eps":0,"marketStatus":"Trading","change":6.37,"latestTime":"09-16 12:15:59 EDT","open":255.78,"high":259.395,"low":250.92,"amount":24534793.51576,"amplitude":0.033846,"askPrice":256.96,"askSize":30,"bidPrice":256.02,"bidSize":30,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1789588800000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":250.4,"sharesOutstanding":3074486,"nav":268.659,"aum":530464172.89,"dividendRate":0.003901,"bidAskSpread":0.003539,"preHourTrading":{"tag":"盘前","latestPrice":254.8128,"preClose":250.4,"latestTime":"09:28 EDT","volume":4289,"amount":1082884.5326099999,"timestamp":1789565312693,"change":4.4128,"changeRate":0.017623,"amplitude":0.012511},"postHourTrading":{"tag":"盘后","latestPrice":251.98,"preClose":250.4,"latestTime":"19:59 EDT","volume":8108,"amount":2036460.6035,"timestamp":1789516773600,"change":1.58,"changeRate":0.00631,"amplitude":0.00631},"volumeRatio":0.863155,"impliedVol":0.9285,"impliedVolPercentile":0.5697},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":1974486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.863155,"shares":1974486,"dividePrice":1.0016,"high":259.395,"amplitude":0.033846,"preClose":250.4,"low":250.92,"week52Low":76.29,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":256.77,"eps":0,"divideRate":0.003901,"volume":96008,"delay":0,"ttmEps":0,"open":255.78,"prevYearClose":159.39,"prevWeekClose":261.3,"prevMonthClose":296.31,"prevQuarterClose":292.1,"fiveDayClose":279.02,"twentyDayClose":289.98,"sixtyDayClose":230.01},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2667984681","title":"Solid Biosciences' Duchenne Muscular Dystrophy Approach, FDA Shift Support Upside, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2667984681","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667984681?lang=en_us&edition=fundamental","pubTime":"2026-09-16 23:16","pubTimestamp":1789571771,"startTime":"0","endTime":"0","summary":"Solid Biosciences'  differentiated approach to Duchenne muscular dystrophy and a \"materially different\" leadership at the US Food and Drug Administration could support upside, RBC Capital Markets said in a Wednesday note.The investment firm sees differentiation in the company's gene therapy construct, steroid-only prophylactic regimen, safety profile, consistent expression and biomarkers.While the company's gene therapy is yet to demonstrate functional outcomes, RBC said it is optimistic that upcoming data readouts will show meaningful separation from natural history.The company has dosed 53 patients so far, while a randomized, placebo-controlled confirmatory trial is already up and running, according to the note.The investment firm estimates a more than $1 billion peak opportunity for Solid Biosciences' DMD program and said most US patients remain untreated.RBC initiated coverage with an outperform rating and a $18 price target.Price: 8.46, Change: +0.09, Percent Change: +1.08","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","BK4588","BK4585","LABU","SLDB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667984969","title":"Philips Wins Top ITEA Awards for AI‑Driven Healthcare and Sensing Innovation","url":"https://stock-news.laohu8.com/highlight/detail?id=2667984969","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667984969?lang=en_us&edition=fundamental","pubTime":"2026-09-16 23:13","pubTimestamp":1789571600,"startTime":"0","endTime":"0","summary":"An announcement from Koninklijke Philips N.V. ( ($NL:PHIA) ) is now available. Royal Philips has led two research collaborations that received top ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/philips-wins-top-itea-awards-for-aidriven-healthcare-and-sensing-innovation?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/philips-wins-top-itea-awards-for-aidriven-healthcare-and-sensing-innovation?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCSG","AIPO","CHAT","XBI","BK4588","BK4585","XLV","VTHR","BK4581","LU0029874061.USD","BK4137","LABU","LU0128526141.USD","QTOC","AGIX","ARTY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667985175","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2667985175","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667985175?lang=en_us&edition=fundamental","pubTime":"2026-09-16 21:02","pubTimestamp":1789563772,"startTime":"0","endTime":"0","summary":"Healthcare stocks were edging higher pre-bell Wednesday, with the State Street Health Care Select Sector SPDR ETF  up 0.2% and the iShares Biotechnology ETF  advancing by 0.9%.Twist Bioscience  stock was up more than 4% after the company said it has agreed to provide antibody characterization data services to Lilly TuneLab, an AI/ML drug discovery platform created by Eli Lilly .","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CURE","IE0005OL40V9.USD","LU2237438978.USD","LLII","BK4588","LU0787776722.HKD","SGXZ57979304.SGD","BK4516","IE00B7KXQ091.USD","MEDI","SGXZ31699556.SGD","LU2361045086.USD","SGXZ99366536.SGD","LU0094547139.USD","IE0004445015.USD","SG9999001176.SGD","SG9999015986.USD","GB00BDT5M118.USD","BK4534","LU0122379950.USD","SG9999014898.SGD","LU2023251221.USD","SG9999015978.USD","LU0203201768.USD","LU0266013472.USD","LU1804176565.USD","LU0354030511.USD","LU0198837287.USD","IE00BWXC8680.SGD","LU2471134796.USD","LU2213496289.HKD","LU2552382058.USD","LU1983299246.USD","LU1691799644.USD","LU2271345857.HKD","LU2361044949.HKD","LU1720051108.HKD","LU0174119429.USD","SG9999013999.USD","LU2462591350.SGD","LU0256863811.USD","LU1868836914.USD","LU2756315664.SGD","LU0353189763.USD","LU2456880835.USD","LU2491050071.SGD","LU1629891620.HKD","IE00B1XK9C88.USD","IE00B4R5TH58.HKD","LU0786609619.USD","LU0820561909.HKD","LU1988902786.USD","LU0114720955.EUR","SG9999014914.USD","IE00BJJMRX11.SGD","IE00BJJMRY28.SGD","LU1623119135.USD","HRTS","LU2361044865.SGD","LU2491049909.HKD","LU1232071149.USD","SG9999015952.SGD","LU0466842654.USD","LU2168564495.EUR","LU2491050154.USD","LU1064131342.USD","LU2471134952.CNY","SG9999015945.SGD","IDNA","SG9999017495.SGD","LU2264538146.SGD","TRUH","LU2756315318.SGD","LU2236285917.USD","IE00B4JS1V06.HKD","ELIS","LU0820561818.USD","XLV","LU2237443382.USD","LU0683600562.USD","LU1127390331.HKD","THNR","LU0385154629.USD","LU0417517546.SGD","LU2471134523.USD","LU1291159041.SGD","IYH","LU1057294990.SGD","LU1868837300.USD","SG9999014880.SGD","IE00B2B36J28.USD","FTXH","BK4533","LU2552382132.HKD","LU1280957306.USD","SG9999001176.USD","LABU","LU0640476718.USD","SGXZ51526630.SGD","LU2462157665.USD","LU1868836757.USD","IBB","MEDX","LU2417539215.USD","LU2108987350.USD","WDNA","LU2089284900.SGD","LU0061475181.USD","ARKG","LU0133085943.USD","LU0353189680.USD","LU2023250330.USD","LLYX","LU0158827781.USD","SG9999014906.USD","VHT","AGNG","PJP","LU0345770993.USD","LU0289739699.SGD","LU2324357040.USD","LU0203202063.USD","LU1814569148.SGD","LU1868837136.USD","LU2168564065.EUR","LU0345770308.USD","LU0432979614.USD","LU1989771016.USD","LU0823416689.USD","BK4139","LU0210536198.USD","LU0320765992.SGD","LU0096364046.USD","IE00BK4W5M84.HKD","IE00BKDWB100.SGD","LU2087625088.SGD","JDOC","IE00BJLML261.HKD","LU2023250504.SGD","LU2089984988.USD","LU1551013425.SGD","LU1035775433.USD","LU2602419157.SGD","IE00B775H168.HKD","LU2237443465.HKD","LU2089283258.USD","GNOM","LU0471298694.HKD","LU0882574055.USD","LU2265009873.SGD","IE00BFSS8Q28.SGD","LU2237443978.SGD","LU2471134879.HKD","LU0323591593.USD","IE00BN29S564.USD","LU2063271972.USD","LU0106261372.USD","LU2357305700.SGD","IE0009355771.USD","LU2237443895.HKD","SGXZ81514606.USD","LU0471298777.SGD","LU2028103732.USD","LU2360106947.USD","LU2552382215.SGD","LU2106854487.HKD","CANC","LU0109391861.USD","FHLC","ILDR","LU0097036916.USD","LU1093756325.SGD","LU1712237335.SGD","LU2237443549.SGD","RXL","MHIP","LU1974910355.USD","LU0943347566.SGD","LU2168563687.JPY","LU1023059063.AUD","PPH","LU2896262040.SGD","XBI","LU2750360641.GBP","BK4581","LU2237443622.USD","LU0672654240.SGD","IXJ","LU0823434740.USD","IE0002141913.USD","LU0109394709.USD","IE00BFSS7M15.SGD","LU2750360997.AUD","LU0820562030.AUD","SG9999018857.SGD","LU0964807845.USD","LU1548497426.USD","IE00BJJMRZ35.SGD","IE0001KFT4U8.USD","LU0225283273.USD","GDOC","LU1366192091.USD","LU0006306889.USD","LU1145028129.USD","LU0320765059.SGD","LU0354030438.USD","LU1061106388.HKD","LU2468319806.SGD","LU2111349929.HKD","LLYZ","LU1551013342.USD","LU2112291526.USD","IE00B1BXHZ80.USD","LU0256863902.USD","LLY","ELIL","LU1917777945.USD","LU0689472784.USD","LU0823434583.USD","LU1868836591.USD","IE00BFTCPJ56.SGD","LU1069344957.HKD","LU1267930730.SGD","LU0238689110.USD","LU2168564149.EUR","IE00BK4W5L77.USD","LU0316494557.USD","LU0882574139.USD","IE00BJT1NW94.SGD","LU0079474960.USD","LU2211815571.USD","IE00BKPKM429.USD","LU0158827948.USD","LU1720051017.SGD","BK4585","LU1979441026.SGD","LU0234572021.USD","LU2168564222.USD","BK4599","IE0004445239.USD","LU0456855351.SGD","OZEM","IHE","LU1093756168.USD","LU0708995401.HKD","LU0889565916.HKD","LU1323610961.USD","TWST","SG9999018865.SGD","LU2746668974.SGD","LU2746668461.USD","TMED","LU0058720904.USD","BK4007","LU2461242641.AUD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667986322","title":"NeOnc’s $629K Insider Buying Spree Follows Breakthrough Data and Now All Eyes Turn to the FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2667986322","media":"GlobeNewswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667986322?lang=en_us&edition=fundamental","pubTime":"2026-09-16 20:46","pubTimestamp":1789562760,"startTime":"0","endTime":"0","summary":"DENVER, Sept.  16, 2026 (GLOBE NEWSWIRE) -- (247marketnews.com) -- NeOnc Technologies Holdings (NASDAQ: NTHI) executives put even more personal capital behind the company, following positive Phase 2a ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/16/3363189/0/en/neonc-s-629k-insider-buying-spree-follows-breakthrough-data-and-now-all-eyes-turn-to-the-fda.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","NTHI","BK4588","SHAP.U","LABU","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667979600","title":"Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), Ascendis Pharma (ASND) and Charles River Labs (CRL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2667979600","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667979600?lang=en_us&edition=fundamental","pubTime":"2026-09-16 19:20","pubTimestamp":1789557614,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Vertex Pharmaceuticals (VRTX), Ascendis Pharma (ASND...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-vertex-pharmaceuticals-vrtx-ascendis-pharma-asnd-and-charles-river-labs-crl-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-vertex-pharmaceuticals-vrtx-ascendis-pharma-asnd-and-charles-river-labs-crl-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1674673428.USD","LU2236285917.USD","BK4585","LU1069344957.HKD","HCSG","LU0109394709.USD","LU2324357040.USD","IE00B894F039.SGD","IE0009355771.USD","IE00BZ9MQY76.HKD","BK4533","LU0289739699.SGD","IBB","BK4588","LU0390134368.USD","LU2417539215.USD","TBXU","IE00BJJMRZ35.SGD","CRL","BBH","LU1035775433.USD","XLV","BK4581","LU0061475181.USD","PBE","SGXZ57979304.SGD","LU2462157665.USD","LABU","ASND","VRTX","LU2362540622.SGD","LU2362541273.HKD","LU2237438978.USD","LU1430594728.SGD","LU0757428866.USD","LU1778281490.HKD","MEDI","GNMX","LU0889565916.HKD","LU0029874061.USD","LU1559883803.SGD","LU1585245621.USD","LU1093756168.USD","IBBQ","IDNA","BK4023","LU1093756325.SGD","XBI","VERX","BIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667600940","title":"Analysts Offer Insights on Healthcare Companies: Viatris (VTRS) and Vera Therapeutics (VERA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2667600940","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667600940?lang=en_us&edition=fundamental","pubTime":"2026-09-16 19:10","pubTimestamp":1789557055,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Viatris (VTRS) and Vera Therapeutics (VERA). Viatr...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-viatris-vtrs-and-vera-therapeutics-vera-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-viatris-vtrs-and-vera-therapeutics-vera-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","LU0029874061.USD","BK4539","LU2087621335.USD","XBI","VERA","HCSG","XLV","BK4588","BK4139","BK4007","LU1839511570.USD","LU2324357040.USD","LU0128526141.USD","BK4581","BK4585","VTRS","BK4137","BK4583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667072336","title":"NRX Pharmaceuticals Gains FDA Boost for Ketamine Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2667072336","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667072336?lang=en_us&edition=fundamental","pubTime":"2026-09-16 18:45","pubTimestamp":1789555526,"startTime":"0","endTime":"0","summary":"NRX Pharmaceuticals ( ($NRXP) ) has issued an update. On Sept. 15, 2026, NRx Pharmaceuticals reported that the U.S. Food and Drug Administration’s ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/nrx-pharmaceuticals-gains-fda-boost-for-ketamine-review?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/nrx-pharmaceuticals-gains-fda-boost-for-ketamine-review?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667078256","title":"Analysts’ Top Healthcare Picks: Alnylam Pharma (ALNY), Scholar Rock Holding (SRRK)","url":"https://stock-news.laohu8.com/highlight/detail?id=2667078256","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667078256?lang=en_us&edition=fundamental","pubTime":"2026-09-16 18:30","pubTimestamp":1789554624,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Alnylam Pharma (ALNY), Scholar Rock Holding (SRRK) a...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-alnylam-pharma-alny-scholar-rock-holding-srrk-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-alnylam-pharma-alny-scholar-rock-holding-srrk-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0114720955.EUR","GNMX","XBI","BK4588","LU0320765992.SGD","ALNY","LABU","SRRK","IBRN","THNR","BK4137","BK4548","BK4581","PBE","LU0889565916.HKD","LU0128526141.USD","LU0109394709.USD","LU0029874061.USD","LU0882574055.USD","BK4585","HCSG","BK4139","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667388604","title":"Meinian Onehealth Healthcare Holdings Shareholder Reduces Stake","url":"https://stock-news.laohu8.com/highlight/detail?id=2667388604","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667388604?lang=en_us&edition=fundamental","pubTime":"2026-09-16 17:47","pubTimestamp":1789552072,"startTime":"0","endTime":"0","summary":"Meinian Onehealth Healthcare Holdings (SHE:002044) shareholder Hangzhou Haoyue Enterprise Management reduced its shareholding by 42.9 million shares, equivalent to 1.1% of the entire share capital of the healthcare company, according to a Wednesday filing with the Shenzhen bourse.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0029874061.USD","BK4588","BK4137","LU2097828557.USD","XLV","BK4581","BK4585","BK0077","BK0146","LU2097828474.EUR","LU2097828714.EUR","BK0114","LU2097828631.EUR","LU2097828805.USD","LU0128526141.USD","002044","HCSG","BK0028","LABU","BK0196","BK0236","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667197605","title":"Sigma Healthcare Director Neville Mitchell Boosts Shareholding","url":"https://stock-news.laohu8.com/highlight/detail?id=2667197605","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667197605?lang=en_us&edition=fundamental","pubTime":"2026-09-16 15:57","pubTimestamp":1789545449,"startTime":"0","endTime":"0","summary":"Sigma Healthcare Ltd ( ($AU:SIG) ) has provided an update. Sigma Healthcare director Neville Mitchell has increased his direct holding of ordinary ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/sigma-healthcare-director-neville-mitchell-boosts-shareholding?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/sigma-healthcare-director-neville-mitchell-boosts-shareholding?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0029874061.USD","XBI","BK4585","XLV","BK4581","HCSG","LU0128526141.USD","BK4137","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667605170","title":"Positive Report for Alvotech (ALVO) from Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2667605170","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667605170?lang=en_us&edition=fundamental","pubTime":"2026-09-16 15:55","pubTimestamp":1789545319,"startTime":"0","endTime":"0","summary":"Barclays analyst Glen Santangelo upgraded Alvotech to a Buy today and set a price target of $8.00. Santangelo covers the Healthcare sector, focusin...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/positive-report-for-alvotech-alvo-from-barclays-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/positive-report-for-alvotech-alvo-from-barclays-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALVO","XBI","LABU","BK4581","BK4585","XLV","BK4588","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193890895","title":"Singapore Healthcare Firm LYC Healthcare Sets IPO Price at $4 Per Share, Upsizes Offering by 67% to $25 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1193890895","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193890895?lang=en_us&edition=fundamental","pubTime":"2026-09-16 14:39","pubTimestamp":1789540756,"startTime":"0","endTime":"0","summary":"LYC Healthcare, a Singapore-based operator of medical clinics and an orthopedic surgery center, has raised the proposed size of its upcoming initial public offering on Tuesday. The company now...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["STmain","BK4588","UUP","UDN","IPOS","BK4581","MEDX","XLV","XBI","BK4585","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667672265","title":"Amplia Showcases FAK Oncology Pipeline at E&P Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2667672265","media":"TIPRANKS","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667672265?lang=en_us&edition=fundamental","pubTime":"2026-09-16 13:17","pubTimestamp":1789535866,"startTime":"0","endTime":"0","summary":"An announcement from Amplia Therapeutics ( ($AU:ATX) ) is now available. Amplia Therapeutics said Chief Executive Officer and Managing Director Dr ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/amplia-showcases-fak-oncology-pipeline-at-ep-healthcare-conference?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/amplia-showcases-fak-oncology-pipeline-at-ep-healthcare-conference?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","BK4585","LABU","LU0029874061.USD","LU0128526141.USD","BK4137","BK4581","XBI","HCSG","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667760666","title":"Aurobindo Pharma's API Unit Receives One US FDA Observation","url":"https://stock-news.laohu8.com/highlight/detail?id=2667760666","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667760666?lang=en_us&edition=fundamental","pubTime":"2026-09-16 10:14","pubTimestamp":1789524853,"startTime":"0","endTime":"0","summary":"Aurobindo Pharma  said a U.S. FDA inspection of its API manufacturing facility in Telangana concluded with one procedural observation, according to a Tuesday exchange filing.The inspection of Unit-2 of wholly owned subsidiary Apitoria Pharma was conducted from Sept. 7 to Sept. 15, the company said.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["OTX.SI","BK4588","LABU","BK4585","BK6100","BK6520"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667462017","title":"EBR Systems Plans FDA Label Update for WiSE System in Q4","url":"https://stock-news.laohu8.com/highlight/detail?id=2667462017","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667462017?lang=en_us&edition=fundamental","pubTime":"2026-09-16 07:31","pubTimestamp":1789515117,"startTime":"0","endTime":"0","summary":"EBR Systems  plans to submit a changes being effected  premarket approval supplement to the US Food and Drug Administration  in the fourth quarter to proactively update the WiSE System's commercial labelling, with greater emphasis on echo-induced pacing risks and mitigation strategies, according to a Wednesday filing with the Australian bourse.The company said it met with the FDA to discuss the plan, responded to the regulator's questions, and secured agreement on the proposed approach, per the filing.The CBE pathway will enable labelling safety enhancements to be implemented during the review process, helping support patient safety as commercial rollout of the WiSE System expands, the filing added.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7007","BK4585","CBE.AU","LABU","BK7095","BK4588","EBR.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667620262","title":"Emyria takes Australian psychedelic treatment model to U.S. FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2667620262","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667620262?lang=en_us&edition=fundamental","pubTime":"2026-09-16 07:28","pubTimestamp":1789514883,"startTime":"0","endTime":"0","summary":"Emyria Ltd ( ($AU:EMD) ) has issued an announcement. Emyria Limited, an Australian leader in innovative mental health treatments, specialises in ps...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/emyria-takes-australian-psychedelic-treatment-model-to-u-s-fda?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/emyria-takes-australian-psychedelic-treatment-model-to-u-s-fda?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4588","MNTL","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667203276","title":"Dimerix to Showcase Kidney Disease Pipeline and Growth Strategy at E&P Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2667203276","media":"TIPRANKS","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667203276?lang=en_us&edition=fundamental","pubTime":"2026-09-16 07:00","pubTimestamp":1789513209,"startTime":"0","endTime":"0","summary":"An update from Dimerix Limited ( ($AU:DXB) ) is now available. Dimerix Limited will present its strategic and clinical progress at the E&P Healthca...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/dimerix-to-showcase-kidney-disease-pipeline-and-growth-strategy-at-ep-healthcare-conference?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/dimerix-to-showcase-kidney-disease-pipeline-and-growth-strategy-at-ep-healthcare-conference?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LU0029874061.USD","BK4137","HCSG","BK4581","XBI","LABU","LU0128526141.USD","XLV","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667622791","title":"Beta Bionics Secures FDA Clearance for Mint Patch Pump","url":"https://stock-news.laohu8.com/highlight/detail?id=2667622791","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667622791?lang=en_us&edition=fundamental","pubTime":"2026-09-16 05:19","pubTimestamp":1789507159,"startTime":"0","endTime":"0","summary":"Beta Bionics, Inc. ( ($BBNX) ) just unveiled an announcement. On September 14, 2026, Beta Bionics announced U.S. FDA clearance for Mint, a patch pu...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/beta-bionics-secures-fda-clearance-for-mint-patch-pump?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/beta-bionics-secures-fda-clearance-for-mint-patch-pump?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4585","BBNX","LABU","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667062221","title":"Health Care Down, but not by Much, on Rotation to Less Inflation-Sensitive Areas","url":"https://stock-news.laohu8.com/highlight/detail?id=2667062221","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667062221?lang=en_us&edition=fundamental","pubTime":"2026-09-16 05:19","pubTimestamp":1789507140,"startTime":"0","endTime":"0","summary":"Health-care companies fell, but not by as much as the broad market, as traders rotated into a sector less susceptible to inflation and interest-rate concerns.Cancer-treatment developer Legend Biotech plans to name Novartis executive Ingrid Zhang as chief executive.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4581","LABU","BK4585","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667622780","title":"Indivior accelerates transition from RB manufacturing agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2667622780","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667622780?lang=en_us&edition=fundamental","pubTime":"2026-09-16 05:05","pubTimestamp":1789506300,"startTime":"0","endTime":"0","summary":"An update from Indivior ( ($INDV) ) is now available. On September 9, 2026, Indivior UK Limited and Reckitt Benckiser Healthcare (UK) Limited agree...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/indivior-accelerates-transition-from-rb-manufacturing-agreement?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/indivior-accelerates-transition-from-rb-manufacturing-agreement?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","BK4585","EES","LABU","BK4007","INDV","UK","BK4528","BK4581","XBI","BK4233","BK4205","BK4588"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":21,"pageCount":1,"totalSize":414,"code":"91000000","status":"200"}]}}